ANGELA BARNES: Open Payments
NPI 1760952410 · WHITE PLAINS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 23 payments from 7 companies in 2025. Trend: 2023 $598 · 2024 $492 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 9 | $208 |
| Boston Scientific Corporation | 9 | $180 |
| Averitas Pharma Inc. | 1 | $22 |
| SCILEX PHARMACEUTICALS INC. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Medtronic, Inc. | 1 | $16 |
| Nalu Medical, Inc. | 1 | $14 |
Products named: XTAMPZA, General - Pain Management, Belbuca, QUTENZA, ZTLido, JOURNAVX, INCEPTIV, Nalu Neurostimulation System.
Industry payments across MD — which companies pay providers there.
